| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
67,918 |
57,181 |
$6.07M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
42,543 |
36,459 |
$5.86M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,632 |
2,547 |
$1.34M |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
3,690 |
2,549 |
$1.14M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
9,253 |
7,588 |
$1.13M |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
4,706 |
4,640 |
$1.11M |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,084 |
2,998 |
$880K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,852 |
2,827 |
$762K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,474 |
12,371 |
$754K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
8,174 |
6,405 |
$706K |
| 99201 |
|
3,868 |
2,781 |
$696K |
| 0450 |
Emergency room services |
4,859 |
4,390 |
$657K |
| 71250 |
|
2,469 |
2,453 |
$633K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,312 |
2,228 |
$578K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
956 |
920 |
$556K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,082 |
2,729 |
$466K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
2,960 |
2,910 |
$449K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,622 |
6,810 |
$432K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,455 |
2,383 |
$353K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,482 |
4,163 |
$350K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,654 |
1,580 |
$320K |
| 76830 |
Ultrasound, transvaginal |
1,993 |
1,926 |
$290K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
536 |
529 |
$281K |
| 71045 |
Radiologic examination, chest; single view |
10,586 |
9,800 |
$279K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,407 |
1,250 |
$273K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,157 |
3,333 |
$264K |
| 71046 |
Radiologic examination, chest; 2 views |
6,659 |
6,497 |
$259K |
| 80053 |
Comprehensive metabolic panel |
25,671 |
22,670 |
$253K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,774 |
4,530 |
$247K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
41 |
41 |
$243K |
| J3490 |
Unclassified drugs |
45,087 |
24,556 |
$237K |
| 93971 |
|
1,092 |
1,073 |
$230K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
29,743 |
25,687 |
$209K |
| Z7502 |
|
4,949 |
4,832 |
$187K |
| 76642 |
|
1,445 |
1,406 |
$185K |
| 76801 |
|
1,479 |
1,322 |
$183K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,220 |
1,121 |
$177K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,363 |
1,316 |
$165K |
| 73630 |
|
2,954 |
2,880 |
$152K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
280 |
277 |
$151K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
219 |
216 |
$129K |
| 73562 |
|
2,588 |
2,548 |
$128K |
| 73610 |
|
1,914 |
1,876 |
$115K |
| 76770 |
|
884 |
872 |
$112K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
825 |
803 |
$112K |
| 73221 |
|
207 |
203 |
$109K |
| 73030 |
|
1,787 |
1,732 |
$103K |
| 77065 |
Tomosynthesis, mammo |
484 |
459 |
$101K |
| 73130 |
|
1,557 |
1,523 |
$92K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
10,155 |
8,191 |
$90K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,371 |
1,305 |
$85K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
608 |
507 |
$82K |
| 84484 |
|
8,378 |
5,646 |
$82K |
| 72100 |
|
1,232 |
1,208 |
$80K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,797 |
1,627 |
$78K |
| 99199 |
Unlisted special service, procedure or report |
757 |
668 |
$77K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
9,096 |
4,638 |
$75K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
863 |
846 |
$74K |
| 83880 |
|
2,278 |
2,116 |
$72K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
438 |
402 |
$71K |
| 76536 |
|
691 |
677 |
$70K |
| 74018 |
|
1,701 |
1,537 |
$70K |
| 77066 |
Tomosynthesis, mammo |
219 |
212 |
$68K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
7,099 |
6,713 |
$64K |
| 83690 |
|
9,413 |
8,563 |
$62K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,215 |
6,184 |
$58K |
| 81001 |
|
12,704 |
11,890 |
$56K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
2,974 |
1,457 |
$55K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
349 |
331 |
$52K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,922 |
6,444 |
$52K |
| 82077 |
|
1,577 |
1,447 |
$51K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,101 |
2,241 |
$47K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
97 |
81 |
$47K |
| 73110 |
|
812 |
782 |
$46K |
| 87040 |
|
3,204 |
1,863 |
$42K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
44 |
42 |
$41K |
| 90715 |
|
950 |
938 |
$41K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
522 |
517 |
$41K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,001 |
986 |
$40K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
958 |
943 |
$36K |
| 73502 |
|
568 |
561 |
$35K |
| 83605 |
|
3,278 |
2,463 |
$33K |
| 93017 |
|
204 |
203 |
$33K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,066 |
2,590 |
$30K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
52 |
51 |
$27K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,284 |
3,134 |
$25K |
| 80143 |
|
728 |
654 |
$24K |
| 93351 |
|
60 |
60 |
$23K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,702 |
3,176 |
$23K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
317 |
303 |
$22K |
| 80179 |
|
701 |
635 |
$22K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,042 |
2,811 |
$22K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,367 |
2,188 |
$22K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,346 |
2,100 |
$21K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
49 |
49 |
$20K |
| 81025 |
|
5,704 |
5,347 |
$20K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,949 |
3,052 |
$20K |
| 87077 |
|
2,104 |
1,921 |
$19K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
12 |
12 |
$18K |
| 87186 |
|
1,902 |
1,766 |
$18K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
650 |
622 |
$18K |
| J2704 |
Injection, propofol, 10 mg |
2,196 |
1,842 |
$17K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,342 |
1,818 |
$17K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,467 |
1,608 |
$16K |
| 83735 |
|
2,368 |
2,117 |
$14K |
| 84443 |
Thyroid stimulating hormone (TSH) |
719 |
704 |
$12K |
| 85610 |
|
3,088 |
2,866 |
$12K |
| 85730 |
|
1,875 |
1,755 |
$11K |
| 81003 |
|
4,360 |
4,166 |
$11K |
| 73140 |
|
342 |
333 |
$11K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,508 |
1,011 |
$11K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,265 |
1,149 |
$11K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
473 |
397 |
$11K |
| 82947 |
|
2,381 |
2,109 |
$10K |
| 82803 |
|
733 |
668 |
$10K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,331 |
1,182 |
$9K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
13 |
13 |
$9K |
| J2060 |
Injection, lorazepam, 2 mg |
1,297 |
1,114 |
$8K |
| 72040 |
|
128 |
124 |
$8K |
| 70486 |
|
27 |
27 |
$8K |
| 73080 |
|
146 |
142 |
$8K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
913 |
809 |
$8K |
| 76870 |
|
64 |
63 |
$7K |
| J1815 |
Injection, insulin, per 5 units |
422 |
273 |
$7K |
| 99070 |
|
339 |
250 |
$7K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
88 |
77 |
$7K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
13 |
12 |
$6K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
28 |
26 |
$6K |
| 86900 |
|
2,037 |
1,368 |
$6K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
14 |
13 |
$6K |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
308 |
170 |
$5K |
| 84702 |
|
376 |
314 |
$5K |
| 74019 |
|
85 |
77 |
$4K |
| 86901 |
|
1,590 |
1,462 |
$4K |
| 94644 |
|
119 |
114 |
$4K |
| 12001 |
|
104 |
103 |
$4K |
| J2785 |
Injection, regadenoson, 0.1 mg |
26 |
25 |
$4K |
| 87400 |
|
394 |
390 |
$4K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
528 |
240 |
$4K |
| 87430 |
|
236 |
235 |
$3K |
| 87081 |
|
290 |
288 |
$3K |
| 10060 |
|
58 |
58 |
$3K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
167 |
134 |
$2K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
214 |
209 |
$2K |
| 86850 |
|
693 |
643 |
$2K |
| Z7610 |
|
233 |
126 |
$2K |
| 86922 |
|
27 |
13 |
$2K |
| 73590 |
|
13 |
12 |
$2K |
| 93350 |
|
13 |
13 |
$2K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
29 |
19 |
$2K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
197 |
193 |
$2K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
119 |
113 |
$2K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
12 |
12 |
$2K |
| 96367 |
|
19 |
16 |
$1K |
| 94729 |
|
13 |
13 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
128 |
109 |
$1K |
| 85379 |
|
140 |
133 |
$1K |
| 94726 |
|
13 |
13 |
$1K |
| 84100 |
|
330 |
311 |
$1K |
| 71101 |
|
12 |
12 |
$1K |
| 84132 |
|
297 |
280 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
297 |
264 |
$1K |
| 71020 |
|
22 |
16 |
$1K |
| 94060 |
|
13 |
13 |
$932.10 |
| 87210 |
|
142 |
142 |
$849.23 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
61 |
38 |
$817.38 |
| J1940 |
Injection, furosemide, up to 20 mg |
84 |
63 |
$620.24 |
| 73521 |
|
12 |
12 |
$569.64 |
| 74000 |
|
18 |
16 |
$507.11 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
39 |
39 |
$503.53 |
| 84295 |
|
159 |
154 |
$488.68 |
| S0028 |
Injection, famotidine, 20 mg |
64 |
50 |
$482.77 |
| 29125 |
|
26 |
25 |
$437.87 |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
38 |
31 |
$431.71 |
| 0250 |
|
23 |
13 |
$413.74 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
25 |
20 |
$367.44 |
| 87420 |
|
68 |
57 |
$269.88 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
517 |
478 |
$215.97 |
| 87088 |
|
32 |
27 |
$197.64 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
19 |
17 |
$159.90 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
13 |
12 |
$152.49 |
| 85027 |
|
32 |
27 |
$148.55 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
29 |
29 |
$129.34 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
512 |
494 |
$118.55 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
19 |
15 |
$117.95 |
| A4217 |
Sterile water/saline, 500 ml |
12 |
12 |
$99.19 |
| 82009 |
|
12 |
12 |
$85.92 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
54 |
54 |
$78.24 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
38 |
36 |
$68.86 |
| 87205 |
|
12 |
12 |
$51.90 |
| 85652 |
|
26 |
26 |
$46.55 |